Kim YC - Search Results

1

Discovery of Novel Pyrimidine-Based Capsid Assembly Modulators as Potent Anti-HBV Agents.

Kim W, Kang JA, Park M, Jeong PH, Kim YJ, Cho Y, Park SG, Kim YC. Kim W, et al. Among authors: kim yj, kim yc. J Med Chem. 2021 May 13;64(9):5500-5518. doi: 10.1021/acs.jmedchem.0c01938. Epub 2021 Apr 22. J Med Chem. 2021. PMID: 33887912

2

N6-substituted D-4'-thioadenosine-5'-methyluronamides: potent and selective agonists at the human A3 adenosine receptor.

Jeong LS, Jin DZ, Kim HO, Shin DH, Moon HR, Gunaga P, Chun MW, Kim YC, Melman N, Gao ZG, Jacobson KA. Jeong LS, et al. Among authors: kim ho, kim yc. J Med Chem. 2003 Aug 28;46(18):3775-7. doi: 10.1021/jm034098e. J Med Chem. 2003. PMID: 12930138

3

Structure-activity relationships of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists.

Jung KY, Kim SK, Gao ZG, Gross AS, Melman N, Jacobson KA, Kim YC. Jung KY, et al. Among authors: kim sk, kim yc. Bioorg Med Chem. 2004 Feb 1;12(3):613-23. doi: 10.1016/j.bmc.2003.10.041. Bioorg Med Chem. 2004. PMID: 14738972 Free PMC article.

4

Structure-based virtual screening and biological evaluation of potent and selective ADAM12 inhibitors.

Oh M, Im I, Lee YJ, Kim YH, Yoon JH, Park HG, Higashiyama S, Kim YC, Park WJ. Oh M, et al. Among authors: kim yh, kim yc. Bioorg Med Chem Lett. 2004 Dec 20;14(24):6071-4. doi: 10.1016/j.bmcl.2004.09.082. Bioorg Med Chem Lett. 2004. PMID: 15546732

5

Synthesis and structure-activity relationships of novel indirubin derivatives as potent anti-proliferative agents with CDK2 inhibitory activities.

Moon MJ, Lee SK, Lee JW, Song WK, Kim SW, Kim JI, Cho C, Choi SJ, Kim YC. Moon MJ, et al. Among authors: kim ji, kim sw, kim yc. Bioorg Med Chem. 2006 Jan 1;14(1):237-46. doi: 10.1016/j.bmc.2005.08.008. Epub 2005 Sep 22. Bioorg Med Chem. 2006. PMID: 16182537

6

Enhancing effect of indirubin derivatives on 1,25-dihydroxyvitamin D3- and all-trans retinoic acid-induced differentiation of HL-60 leukemia cells.

Kim SH, Kim SW, Choi SJ, Kim YC, Kim TS. Kim SH, et al. Among authors: kim ts, kim sw, kim yc. Bioorg Med Chem. 2006 Oct 1;14(19):6752-8. doi: 10.1016/j.bmc.2006.05.044. Epub 2006 Jun 12. Bioorg Med Chem. 2006. PMID: 16765600

7

Structure-activity relationship studies of spinorphin as a potent and selective human P2X(3) receptor antagonist.

Jung KY, Moon HD, Lee GE, Lim HH, Park CS, Kim YC. Jung KY, et al. Among authors: kim yc. J Med Chem. 2007 Sep 6;50(18):4543-7. doi: 10.1021/jm070114m. Epub 2007 Aug 3. J Med Chem. 2007. PMID: 17676725

8

Synthesis and structure-activity relationship studies of tyrosine-based antagonists at the human P2X7 receptor.

Lee GE, Joshi BV, Chen W, Jeong LS, Moon HR, Jacobson KA, Kim YC. Lee GE, et al. Among authors: kim yc. Bioorg Med Chem Lett. 2008 Jan 15;18(2):571-5. doi: 10.1016/j.bmcl.2007.11.077. Epub 2007 Nov 28. Bioorg Med Chem Lett. 2008. PMID: 18078749 Free PMC article.

9

Novel small molecule activators of beta-catenin-mediated signaling pathway: structure-activity relationships of indirubins.

Park EJ, Choi SJ, Kim YC, Lee SH, Park SW, Lee SK. Park EJ, et al. Among authors: kim yc. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2282-4. doi: 10.1016/j.bmcl.2009.02.083. Epub 2009 Feb 26. Bioorg Med Chem Lett. 2009. PMID: 19282173

10

Structure-activity relationships of heteroaromatic esters as human rhinovirus 3C protease inhibitors.

Im I, Lee ES, Choi SJ, Lee JY, Kim YC. Im I, et al. Among authors: kim yc. Bioorg Med Chem Lett. 2009 Jul 1;19(13):3632-6. doi: 10.1016/j.bmcl.2009.04.114. Epub 2009 May 3. Bioorg Med Chem Lett. 2009. PMID: 19464175 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,318 results

Search Page

Filters